Senior insider sale
CEO - Elect at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$903.0K
58.56K shares
What this filing means
KIM JULIE SO-YOUNG plans to sell 58.56K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $903.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2025ACC: 0001977732-25-000004
Officer· CEO - Elect
Since Mar 2026
58.56K
Shares to sell
$903.0K
Approx. market value
118.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2025
118.67KTotal acquired118.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Restricted Stock Unit Awards - Vested. Compensation | 118.67K | — |
| Total | 118.67K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
58.56K
Market value
$903.0K
7/9/2025
Total
Units
58.56K
Value
$903.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/9/2025 | 58.56K | $903.0K | NYSE | Planned |
| Total | 58.56K | $903.0K | ||